These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 17408770)

  • 1. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
    Teng PR; Shen TY; Lai TJ
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253
    [No Abstract]   [Full Text] [Related]  

  • 3. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
    Vieweg WV; Schneider RK; Wood MA
    Acta Psychiatr Scand; 2005 Oct; 112(4):318-22; author reply 322. PubMed ID: 16156840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
    Joy JP; Coulter CV; Duffull SB; Isbister GK
    Clin Pharmacol Ther; 2011 Aug; 90(2):243-5. PubMed ID: 21716272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
    Chang JH; Weng TI; Fang CC
    Am J Emerg Med; 2009 Oct; 27(8):1016.e1-3. PubMed ID: 19857426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin-induced ventricular arrhythmia.
    Urge J; Sincl F; Procházka V; Urbánek K
    Scand J Gastroenterol; 2008; 43(9):1145-8. PubMed ID: 18609153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
    Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
    Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
    Berling I; Isbister GK
    Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.